Zhang He, Gao Lin, Mao Wen-Jian, Yang Jie, Zhou Jing, Tong Zhi-Hui, Ke Lu, Li Wei-Qin
Medical School of Southeast University, 87 Dingjiaqiao, Nanjing 210009, China; Center of Severe Acute Pancreatitis (CSAP), Department of General Surgery, Jinling Hospital, Medical School of Southeast University, No. 305 Zhongshan East Road, Nanjing 210002, China.
Center of Severe Acute Pancreatitis (CSAP), Department of General Surgery, Jinling Hospital, Medical School of Southeast University, No. 305 Zhongshan East Road, Nanjing 210002, China.
Hepatobiliary Pancreat Dis Int. 2022 Feb;21(1):63-68. doi: 10.1016/j.hbpd.2020.12.019. Epub 2021 Jan 14.
Current guidelines for the treatment of patients with necrotizing acute pancreatitis (NAP) recommend that invasive intervention for pancreatic necrosis should be deferred to 4 or more weeks from disease onset to allow necrotic collections becoming "walled-off". However, for patients showing signs of clinical deterioration, especially those with persistent organ failure (POF), it is controversial whether this delayed approach should always be adopted. In this study, we aimed to assess the impact of differently timed intervention on clinical outcomes in a group of NAP patients complicated by POF.
All NAP patients admitted to our hospital from January 2013 to December 2017 were screened for potential inclusion. They were divided into two groups based on the timing of initial intervention (within 4 weeks and beyond 4 weeks). All the data were extracted from a prospectively collected database.
Overall, 131 patients were included for analysis. Among them, 100 (76.3%) patients were intervened within 4 weeks and 31 (23.7%) underwent delayed interventions. As for organ failure prior to intervention, the incidences of respiratory failure, renal failure and cardiovascular failure were not significantly different between the two groups (P > 0.05). The mortality was not significantly different between the two groups (35.0% vs. 32.3%, P = 0.83). The incidences of new-onset multiple organ failure (8.0% vs. 6.5%, P = 1.00), gastrointestinal fistula (29.0% vs. 12.9%, P = 0.10) and bleeding (35.0% vs. 35.5%, P = 1.00), and length of ICU (30.0 vs. 22.0 days, P = 0.61) and hospital stay (42.5 vs. 40.0 days, P = 0.96) were comparable between the two groups.
Intervention within 4 weeks did not worsen the clinical outcomes in NAP patients complicated by POF.
目前坏死性急性胰腺炎(NAP)患者的治疗指南建议,对于胰腺坏死的侵入性干预应推迟至疾病发作后4周或更长时间,以使坏死灶形成“包裹性”。然而,对于出现临床恶化迹象的患者,尤其是那些伴有持续性器官衰竭(POF)的患者,是否应始终采用这种延迟治疗方法存在争议。在本研究中,我们旨在评估不同时机的干预对一组并发POF的NAP患者临床结局的影响。
对2013年1月至2017年12月期间我院收治的所有NAP患者进行筛选以确定是否可能纳入研究。根据首次干预的时间(4周内和4周后)将他们分为两组。所有数据均从前瞻性收集的数据库中提取。
总体而言,纳入131例患者进行分析。其中,100例(76.3%)患者在4周内接受干预,31例(23.7%)接受延迟干预。干预前器官衰竭方面,两组呼吸衰竭、肾衰竭和心血管衰竭的发生率无显著差异(P>0.05)。两组死亡率无显著差异(35.0%对32.3%,P=0.83)。两组新发多器官衰竭发生率(8.0%对6.5%,P=1.00)、胃肠瘘发生率(29.0%对12.9%,P=0.10)和出血发生率(35.0%对35.5%,P=1.00)以及ICU住院时间(30.0天对22.0天,P=0.61)和住院时间(42.5天对40.0天,P=0.96)相当。
4周内进行干预并未使并发POF的NAP患者临床结局恶化。